• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.07% Nasdaq Up0.32%

    More On RANBAXY.NS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Ranbaxy Laboratories Ltd. (RANBAXY.NS)

    -NSE
    859.80 Up 0.60(0.07%) Apr 1
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2014Dec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 107,620,000   108,017,000   124,542,000   102,295,000  
    Cost of Revenue49,508,000  39,033,000  48,175,000  39,558,000  
    Gross Profit 58,112,000   68,983,000   76,367,000   62,737,000  
    Operating Expenses
    Research Development -   -   -   -  
    Selling General and Administrative -   -   -   -  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses100,213,000  102,270,000  106,931,000  79,784,000  
    Operating Income or Loss 7,407,000   5,747,000   17,611,000   22,511,000  
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -   -  
    Earnings Before Interest And Taxes7,407,000  5,747,000  17,611,000  22,511,000  
    Interest Expense(1,720,000)(2,046,000)(1,367,000)(657,000)
    Income Before Tax -   -   -   -  
    Income Tax Expense2,961,000  2,216,000  2,939,000  1,969,000  
    Minority Interest62,000  (37,000)(96,000)(97,000)
    Net Income From Continuing Ops(12,172,000)(10,079,000)9,324,000  (28,900,000)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (12,110,000) (10,116,000) 9,228,000   (28,997,000)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares -   -   -   -  

    Currency in INR.